CompletedNCT00584961
Metabolic and cardiovascular health in bipolarity
About this title
Read the official source — NCT00584961Observational studyAges 18+
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
Study information
Study start dateMay 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 553
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- Over 18 Years
- Official registry ID
- NCT00584961
- Official title
Show the full official title
BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
